Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors
出版年份 2021 全文链接
标题
Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 30, Issue 12, Pages 1197-1208
出版商
Informa UK Limited
发表日期
2021-12-04
DOI
10.1080/13543784.2021.2014813
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX
- (2021) Utpal K. Mondal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties
- (2021) Shimpei Iikuni et al. MOLECULAR PHARMACEUTICS
- Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities
- (2021) Mostafa M. Elbadawi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer
- (2021) Mam Y. Mboge et al. JOURNAL OF MEDICINAL CHEMISTRY
- Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells
- (2021) Guanzhang Li et al. OncoTargets and Therapy
- Inhibitors of CA IX Enzyme Based on Polyhedral Boron Compounds
- (2021) Michael Kugler et al. CHEMBIOCHEM
- Affinity Selections of DNA‐Encoded Chemical Libraries on Carbonic Anhydrase IX‐Expressing Tumor Cells Reveal a Dependence on Ligand Valence
- (2021) Sebastian Oehler et al. CHEMISTRY-A EUROPEAN JOURNAL
- Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR/CAIX dual inhibitors
- (2021) Bin Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors
- (2021) Moataz Shaldam et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tellurides bearing benzensulfonamide as carbonic anhydrase inhibitors with potent antitumor activity
- (2021) Andrea Angeli et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting of carbonic anhydrase IX-positive cancer cells by glycine-coated superparamagnetic nanoparticles
- (2021) Iryna Antal et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells
- (2021) Ebru Temiz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Betulin Sulfonamides as Carbonic Anhydrase Inhibitors and Anticancer Agents in Breast Cancer Cells
- (2021) Antje Güttler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice
- (2021) Patrizia Garbati et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors
- (2021) Shawn C. Chafe et al. Science Advances
- Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX
- (2021) Pengqin Xu et al. Frontiers in Oncology
- Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides
- (2021) Cem Yamali et al. BIOORGANIC CHEMISTRY
- Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation
- (2021) Diaaeldin M. Elimam et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
- (2021) Assem H. Eldeeb et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide – A new caspase-activating proapoptotic agent
- (2021) Dmitry Dar'in et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A nanoplatform to boost multi-phases of cancer-immunity-cycle for enhancing immunotherapy
- (2021) Cuixia Zheng et al. JOURNAL OF CONTROLLED RELEASE
- Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells
- (2020) Andrea Petreni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity
- (2020) Mikhail Krasavin et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- 1,3-Dipolar Cycloaddition, HPLC Enantioseparation, and Docking Studies of Saccharin/Isoxazole and Saccharin/Isoxazoline Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors
- (2020) Melissa D’Ascenzio et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
- (2020) Paul C. McDonald et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Role of carbonic anhydrases in ferroptosis-resistance
- (2020) Zan Li et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors
- (2020) Davide Moi et al. BIOORGANIC CHEMISTRY
- Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes
- (2020) Vikas Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
- (2020) Claudiu T. Supuran Expert Opinion on Drug Metabolism & Toxicology
- Pharmacological Inhibition of CA-IX Impairs Tumor Cell Proliferation, Migration and Invasiveness
- (2020) Valerio Ciccone et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Azidothymidine (AZT) “clicked” into 1,2,3-Triazoles: First Report on Carbonic Anhydrase-Telomerase Dual Hybrid Inhibitors
- (2020) Emanuela Berrino et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual P-Glycoprotein and CA XII Inhibitors: A New Strategy to Reverse the P-gp Mediated Multidrug Resistance (MDR) in Cancer Cells
- (2020) Elisabetta Teodori et al. MOLECULES
- Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival
- (2020) Shirley Genah et al. PHARMACOLOGICAL RESEARCH
- Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases
- (2020) Perihan A. Elzahhar et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
- (2020) Chandra B. Mishra et al. MEDICINAL RESEARCH REVIEWS
- How and Why Are Cancers Acidic? Carbonic Anhydrase IX and the Homeostatic Control of Tumour Extracellular pH
- (2020) Shen-Han Lee et al. Cancers
- Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII
- (2020) Suleyman Akocak et al. BIOORGANIC CHEMISTRY
- Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents
- (2020) Costanza Ceni et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the HIF2–VEGF axis in renal cell carcinoma
- (2020) Toni K. Choueiri et al. NATURE MEDICINE
- CA IX Stabilizes Intracellular pH to Maintain Metabolic Reprogramming and Proliferation in Hypoxia
- (2020) Martin Benej et al. Frontiers in Oncology
- Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
- (2020) Andrea Angeli et al. Metabolites
- Sortase-Mediated Site-Specific Modification of Interleukin-2 for the Generation of a Tumor-Targeting Acetazolamide–Cytokine Conjugate
- (2020) Baptiste Gouyou et al. ACS Omega
- Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells
- (2020) Marina Petrenko et al. CHEMICO-BIOLOGICAL INTERACTIONS
- 3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies
- (2020) Abdulsalam A.M. Alkhaldi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis
- (2020) Mohamed A. Abdelrahman et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Immunotherapy with immunocytokines and PD-1 blockade enhances the anticancer activity of Small Molecule-Drug Conjugates targeting Carbonic Anhydrase IX
- (2020) Jacopo Millul et al. MOLECULAR CANCER THERAPEUTICS
- PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide
- (2020) Shimpei Iikuni et al. PLoS One
- Radiotracers for positron emission tomography (PET) targeting tumour-associated carbonic anhydrase isoforms
- (2020) Valeria Burianova et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma
- (2019) Prashant Mujumdar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
- (2019) Ismail Koyuncu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Carbonic anhydrases are involved in mitochondrial biogenesis and control the production of lactate by human Sertoli cells
- (2019) Raquel L. Bernardino et al. FEBS Journal
- A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells
- (2019) Mam Y. Mboge et al. BIOCHEMICAL JOURNAL
- Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
- (2019) Paul C. McDonald et al. GASTROENTEROLOGY
- Targeting hypoxia-induced carbonic anhydrase IX enhances immune checkpoint blockade locally and systemically
- (2019) Shawn C Chafe et al. Cancer Immunology Research
- Novel synthesized SLC-0111 thiazole and thiadiazole analogues: Determination of their carbonic anhydrase inhibitory activity and molecular modeling studies
- (2019) Mahmoud F. Abo-Ashour et al. BIOORGANIC CHEMISTRY
- Harnessing Induced Essentiality: Targeting Carbonic Anhydrase IX and Angiogenesis Reduces Lung Metastasis of Triple Negative Breast Cancer Xenografts
- (2019) Hedlund et al. Cancers
- Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
- (2019) Zan Li et al. Redox Biology
- Personalized Treatment Response Assessment for Rare Childhood Tumors Using Microcalorimetry–Exemplified by Use of Carbonic Anhydrase IX and Aquaporin 1 Inhibitors
- (2019) Stephanie J. Gros et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- “A Sweet Combination”: Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII
- (2019) Silvia Bua et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex
- (2019) Vincenzo Alterio et al. JOURNAL OF MOLECULAR BIOLOGY
- Synthesis and biological evaluation of novel N , N ′-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors
- (2018) Suleyman Akocak et al. BIOORGANIC CHEMISTRY
- Design and synthesis of novel 1,3-diaryltriazene-substituted sulfonamides as potent and selective carbonic anhydrase II inhibitors
- (2018) Nabih Lolak et al. BIOORGANIC CHEMISTRY
- UFH-001 cells: A novel triple negative, CAIX-positive, human breast cancer model system
- (2018) Zhijuan Chen et al. CANCER BIOLOGY & THERAPY
- Fully Automated Production and Characterization of 64 Cu and Proof-of-Principle Small-Animal PET Imaging Using 64 Cu-Labelled CA XII Targeting 6A10 Fab
- (2018) Luise Fiedler et al. ChemMedChem
- Enhanced Therapeutic Activity of Non-Internalizing Small-Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination with Targeted Interleukin-2
- (2018) Samuele Cazzamalli et al. CLINICAL CANCER RESEARCH
- Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents
- (2018) Haonan Yu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- An inhibitory antibody targeting Carbonic Anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo
- (2018) Bettina von Neubeck et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX
- (2018) Murat Bozdag et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemically Defined Antibody– and Small Molecule–Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis
- (2018) Samuele Cazzamalli et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
- (2018) Claudiu T. Supuran et al. MEDICINAL RESEARCH REVIEWS
- Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers
- (2018) Isaac S. Marks et al. MOLECULAR PHARMACEUTICS
- Evaluation of 177 Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII
- (2018) L. Fiedler et al. NUCLEAR MEDICINE AND BIOLOGY
- Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity
- (2018) Anne Riemann et al. ONCOLOGY RESEARCH
- Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
- (2018) Shimpei Iikuni et al. Theranostics
- Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents
- (2018) Wagdy M. Eldehna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
- (2018) Claudiu T. Supuran EXPERT OPINION ON INVESTIGATIONAL DRUGS
- SLC-0111 enaminone analogs, 3/4-(3-aryl-3-oxopropenyl) aminobenzenesulfonamides, as novel selective subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform IX
- (2018) Wagdy M. Eldehna et al. BIOORGANIC CHEMISTRY
- Structure activity study of carbonic anhydrase IX: Selective inhibition with ureido-substituted benzenesulfonamides
- (2017) Mam Y. Mboge et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New horizons in hypoxia signaling pathways
- (2017) Christopher W. Pugh et al. EXPERIMENTAL CELL RESEARCH
- Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer
- (2017) Jennifer L Bryant et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of New Selenoureido Analogues of 4-(4-Fluorophenylureido)benzenesulfonamide as Carbonic Anhydrase Inhibitors
- (2017) Andrea Angeli et al. ACS Medicinal Chemistry Letters
- Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111
- (2016) Carrie L. Lomelino et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII
- (2016) Wagdy M. Eldehna et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis and Cytotoxicity of Novel Dihydroartemisinin-Coumarin Hybrids via Click Chemistry
- (2016) Ye Tian et al. MOLECULES
- Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity
- (2015) Cenzo Congiu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
- (2014) Nikolaus Krall et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antitumor Efficacy of a Monoclonal Antibody That Inhibits the Activity of Cancer-Associated Carbonic Anhydrase XII
- (2013) G. Gondi et al. CANCER RESEARCH
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- Antimetastatic Effect of Sulfamate Carbonic Anhydrase IX Inhibitors in Breast Carcinoma Xenografts
- (2012) Roben G. Gieling et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
- (2012) F E Lock et al. ONCOGENE
- Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII
- (2011) Christina Battke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
- (2011) Y. Lou et al. CANCER RESEARCH
- Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
- (2011) Fabio Pacchiano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- Selection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds
- (2010) Fabian Buller et al. ACS Chemical Biology
- Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency
- (2010) Fabio Pacchiano et al. CHEMICAL COMMUNICATIONS
- Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
- (2010) M. Zatovicova et al. CURRENT PHARMACEUTICAL DESIGN
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started